| Description | 1
Day Price Change % | Market Cap | P/E | ROE % | Div. Yield % | Long-Term
Debt to Equity | Price to Book Value | Net Profit Margin % (mrq)  | Price
to Free Cash Flow (mrq) |
|---|---|---|---|---|---|---|---|---|---|
| Sector: Healthcare | -0.40 | 2195.9B | 17.77 | 14.92 | 2.26 | 0.80 | 9.86 | 12.19 | 101.34 |
| Industry: Drug Manufacturers - Major (More Info) | -0.01 | 1061.4B | 14.40 | 21.60 | 3.81 | 0.56 | 9.30 | 18.30 | 86.10 |
| Companies | |||||||||
| Spectrum Pharmaceuticals, Inc. (SPPI) | -1.19 | 52.3M | NA | -29.99 | NA | NA | NA | 51.64 | 9.60 |
| Merck & Co. Inc. (MRK) | 0.38 | 73.5B | 15.09 | 25.00 | 4.40 | 0.25 | NA | 29.22 | 154.97 |
| Pfizer Inc. (PFE) | -0.86 | 124.8B | 13.92 | 13.45 | 6.90 | 0.25 | NA | 22.89 | 30.64 |
| Glaxosmithkline plc (GSK) | 0.31 | 116.8B | 13.97 | 54.40 | 4.60 | 1.84 | NA | 21.89 | 130.08 |
| Novartis AG (NVS) | 0.07 | 120.8B | 9.92 | 14.80 | 2.80 | 0.21 | NA | 20.46 | 131.02 |
| AstraZeneca plc (AZN) | -0.09 | 67.3B | 11.84 | 37.20 | 2.40 | 0.93 | NA | 20.36 | 52.27 |
| Johnson & Johnson (JNJ) | 0.31 | 197.5B | 17.15 | 26.46 | 2.60 | 0.30 | NA | 20.23 | 150.82 |
| Wyeth (WYE) | -0.58 | 54.4B | 12.34 | 24.92 | 2.70 | 0.58 | NA | 18.87 | 46.95 |
| Eli Lilly & Co. (LLY) | -1.41 | 51.7B | 13.05 | 28.93 | 4.10 | 0.31 | NA | 18.62 | 34.73 |
| Abbott Laboratories (ABT) | 0.78 | 87.9B | 21.26 | 24.38 | 2.50 | 0.73 | NA | 18.07 | 139.05 |
| Bristol-Myers Squibb Co. (BMY) | -0.05 | 42.4B | 19.47 | 20.03 | 5.80 | 0.73 | NA | 14.68 | NA |
| APP Pharmaceuticals, Inc. (APPX) | -0.21 | 3.8B | 115.00 | 14.99 | NA | NA | NA | 12.07 | 330.75 |
| WuXi PharmaTech (Cayman) Inc. (WX) | -0.06 | 1.1B | 31.82 | 22.82 | NA | 0.17 | NA | 12.03 | NA |
| Schering-Plough Corp. (SGP) | 0.52 | 31.3B | NA | -18.30 | 1.30 | 0.83 | NA | 8.86 | 74.63 |
| Sanofi-Aventis (SNY) | -0.15 | 85.9B | 12.47 | 11.29 | 4.90 | 0.16 | NA | 6.77 | NA |
| Aceto Corp. (ACET) | 5.76 | 220.0M | 23.02 | 7.58 | 2.20 | 0.00 | NA | 3.35 | -20.37 |
| Chem Rx Corporation (CHRX.OB) | NA | NA | NA | 1.79 | NA | 2.02 | NA | -0.30 | NA |
| GeoPharma Inc. (GORX) | 1.60 | 31.0M | NA | -29.09 | NA | 0.83 | NA | -13.06 | 9.94 |
| Boveran Diagnostics, Inc. (BOVD.OB) | NA | NA | NA | NA | NA | NA | NA | -13.18 | NA |
| CPEX Pharmaceuticals, Inc. (CPEX) | 2.25 | 40.7M | NA | NA | NA | NA | NA | -42.73 | -31.35 |
| Oscient Pharmaceuticals Corp. (OSCI) | 0.00 | 16.6M | NA | NA | NA | NA | NA | -82.75 | -2.28 |
| Quick-Med Technologies Inc. (QMDT.OB) | 0.00 | 7.7M | NA | NA | NA | NA | NA | -146.70 | -28.32 |
| Novogen Limited (NVGN) | -3.12 | 139.7M | NA | -56.87 | NA | NA | NA | -165.01 | -45.76 |
| Evotec AG (EVTC) | 0.52 | 420.1M | NA | -30.30 | NA | 0.06 | NA | -166.79 | -87.46 |
| Minrad International Inc. (BUF) | -3.40 | 70.0M | NA | -144.98 | NA | 4.72 | NA | -281.41 | -5.10 |
| Znomics, Inc. (ZNOM.OB) | NA | NA | NA | NA | NA | NA | NA | NA | NA |
| Vertical Health Solutions Inc. (VHSL.OB) | -50.00 | 0.8M | NA | NA | NA | NA | NA | NA | NA |
| Tetragenex Pharmaceuticals, In (TTRX.OB) | NA | NA | NA | NA | NA | NA | NA | NA | NA |
| Rigel Pharmaceuticals, Inc. (RIGL) | 2.07 | 864.4M | NA | -72.84 | NA | 0.01 | NA | NA | -45.76 |
| Provectus Pharmaceuticals, Inc (PVCT.OB) | -2.13 | 70.9M | NA | -75.18 | NA | NA | NA | NA | -20.34 |
| Neurologix Inc. (NRGX.OB) | 0.00 | 23.6M | NA | -44.27 | NA | NA | NA | NA | -20.99 |
| Keryx Biopharmaceuticals Inc. (KERX) | -2.04 | 21.6M | NA | -195.25 | NA | NA | NA | NA | -6.07 |
| Javelin Pharmaceuticals, Inc. (JAV) | -3.28 | 160.6M | NA | -78.54 | NA | NA | NA | NA | -25.46 |
| Inhibiton Therapeutics, Inc. (IHBT.OB) | NA | NA | NA | NA | NA | NA | NA | NA | NA |
| HST Global, Inc. (HSTC.OB) | NA | NA | NA | NA | NA | NA | NA | NA | NA |
| Callisto Pharmaceuticals, Inc. (CLSP.OB) | NA | NA | NA | NA | NA | NA | NA | NA | NA |
| Avigen Inc. (AVGN) | 0.44 | 135.4M | NA | -40.98 | NA | 0.12 | NA | NA | -29.41 |
| AP Pharma Inc. (APPA) | 0.00 | 45.7M | NA | -84.01 | NA | NA | NA | NA | -10.54 |